Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -46.37 | 2.60 |
| PEG Ratio (TTM) | 2.78 | 1.13 |
| P/S Ratio (TTM) | 2.44 | 1.40 |
| P/B Ratio (TTM) | 2.47 | 2.20 |
| P/FCF Ratio (TTM) | 27.91 | 18.10 |
| Price to 5YR AVG Earnings Ratio | -2.66 | -86.22 |
| Price to 5YR AVG FCF Ratio | 16.01 | 17.02 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.96% | 1.16% |
| ROE (TTM) | -5.16% | 17.31% |
| Net Profit Margin (TTM) | -5.29% | 1.69% |
| ROIC 5YR AVG | 5.59% | 18.68% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -35,356.66% | -395.14% | -262.64% |
| Revenue | 5.08% | -18.56% | 17.15% |
| Net Income | -131.93% | -392.91% | -203.50% |
| Cash Flow | 14.36% | 51.04% | 34.14% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.27 | 1.21 |
| Quick Ratio (TTM) | 1.27 | 1.17 |
| D/E Ratio (TTM) | 1.04 | 1.00 |
| Interest Coverage (TTM) | 0.78 | 4.83 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.62 | 2.16 |
| LTL to 5YR AVG FCF | 6.80 | 5.42 |
| Shares Outstanding Growth 5YR AVG | -2.54% | 2.87% |